Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 9644224
Methods for cyclizing synthetic polymers
granted -
US 9642391
Anti-regurgitation composition maintaining gut motility
granted -
US 9644216
Adeno-associated virus vectors for treatment of glycogen storage disease
granted -
US 9644179
Use of PDL1 expressing cells to convert T cells into regulatory T cells
granted -
US 9644039
Acid-degradable and bioerodible modified polyhydroxylated materials
granted -
US 9644201
Structured peptide processing
granted -
US 9644170
Bioeffective krill oil compositions
granted -
US 9644169
Bioeffective krill oil compositions
granted -
US 9642805
Aptamer-loaded, biocompatible nanoconstructs for nuclear-targeted cancer therapy
granted -
US 9644004
Peptide and peptidomimetic inhibitors
granted -
US 9643967
Pyrrolo[3,2-c]pyridine derivatives as TLR inhibitors
granted -
US 9644016
Soluble notch receptor proproteins and methods of use thereof
granted -
US 9644207
Compositions and methods for modulating Tau expression
granted -
US 9643957
Heterocyclic compounds having cholesterol 24-hydroxylase activity
granted -
US 9642946
Medical device with intrapore films
granted -
US 9642894
Compositions for rapidly treating severe hypoglycemia
granted -
US 9642859
Use of capsazepine and analogs thereof to treat cancer
granted -
US 9645139
Neuroprotective chemicals and methods for identifying and using same
granted -
US 9642909
Pharmaceutical compositions comprising attenuated Plasmodium sporozoites and glycolipid adjuvants
granted -
US 9643961
Cyclohexylamine derivatives having β2 adrenergic antagonist and M3 muscarinic antagonist activities
granted -
US 9644238
Methods of isolating non-senescent cardiac stem cells and uses thereof
granted -
US 9642898
Use of serine protease inhibitors in the treatment of neutropenia
granted -
US 9645147
Recombinant polypeptide construct comprising Plasmodium falciparum circumsporozoite protein HLA class I restricted T-cell epitopes
granted -
US 9642916
Porphyrin modified telodendrimers
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.